IMI has provisionally selected 8 projects for funding from its fast-track Call for proposals on coronavirus diagnostics and treatments. The total value of the research funding has reached €117 million.
In total, IMI received 144 proposals in response to the Call, of which 120 met the basic eligibility criteria for IMI support. All eligible proposals were evaluated by independent experts, and due to the large number of high quality proposals, IMI decided to increase the IMI funding allocated to this Call.
Of the eight projects, five focus on diagnostics and three on treatments. The diagnostics projects hope to develop devices that can be used anywhere (including a doctor’s surgery or patient’s home) and will deliver results fast (ranging from 14 to 40 minutes). While the treatment projects focus primarily on the current COVID-19 outbreak, they also include efforts to prepare for future coronavirus outbreaks. The projects form part of the European Commission’s wider response to the coronavirus outbreak.
In total, the projects include 94 organisations, including universities, research organisations, companies, and public bodies. Small and medium-sized enterprises (SMEs) are particularly well represented in the successful proposals, accounting for over 20 % of the participants and 17 % of the budget.
The projects have been selected for funding, pending successful finalisation of the Grant Agreement with IMI. As these projects have not yet signed Grant Agreements, this information is subject to change. Final, more detailed information on the projects will be published after Grant Agreement signature.
See the press release for more information on the selected projects.
Information on IMI2 – Call 21 on the coronavirus
Factsheet on the new projects
Information on other IMI projects’ contributions to coronavirus research
The European Commission's global response to the coronavirus
EFPIA's contribution to the fight against COVID-19